Indalo Therapeutics, Inc.   Report issue

For profit Phase 1
Founded: St Louis MO United States (2013)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2019
NCT03949530
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Indalo Therapeutics, Inc.